SCHEMBL24686802

SCHEMBL24686802

CC1(C)c2ccccc2-c2ccc(-c3ccc(N(c4ccc(-c5ccc6ccccc6c5)cc4)c4ccc(-c5ccc6ccccc6c5)cc4)cc3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.40
LIPG Q9Y5X9 1/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
PDK2 Q15119 9/20 0.39
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
GSTP1 P09211 1/20 0.36
ALOX5 P09917 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24687352 1.00 LPL (0.40) LPLLIPGESR1ESR2PDK2
SCHEMBL10034361 0.97 LPL (0.39) LPLLIPGESR1ESR2PDK2
SCHEMBL10034344 0.97 LPL (0.39) LPLLIPGESR1ESR2PDK2
SCHEMBL23951114 0.97 LPL (0.39) LPLLIPGESR1ESR2PDK2
SCHEMBL23179298 0.96 PDK2 (0.38) LPLLIPGESR1ESR2PDK2
SCHEMBL10034380 0.96 LPL (0.38) LPLLIPGESR1ESR2PDK2
SCHEMBL23180735 0.96 PDK2 (0.38) LPLLIPGESR1ESR2PDK2
SCHEMBL20466609 0.96 LPL (0.40) LPLLIPGESR1ESR2PDK2
SCHEMBL24686801 0.96 LPL (0.40) LPLLIPGESR1ESR2PDK2
SCHEMBL10034405 0.96 LPL (0.40) LPLLIPGESR1ESR2PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LG DISPLAY CO., LTD. (KR) 2022-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LEF1, CLCN2, PIEZO1 LPL 2399/4885LIPG 2572/4885ESR1 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.